Literature DB >> 19300330

Antihypertensive therapy and central hemodynamics in women with hypertensive disorders in pregnancy.

Asma Khalil1, Eric Jauniaux, Kevin Harrington.   

Abstract

OBJECTIVE: To estimate the changes in central hemodynamics features of pregnant women presenting with hypertensive disorders and to analyze the effects of standard antihypertensive treatment on maternal central hemodynamics.
METHODS: Applanation tonometry was used to record the radial artery pulse waveform in 80 women presenting with preeclampsia or gestational hypertension and 80 normotensive controls matched for gestational age. In each case, an averaged aortic waveform was derived and analyzed to calculate augmentation pressure and augmentation index at heart rate 75 beats per minute (bpm).
RESULTS: In women with preeclampsia and gestational hypertension, both augmentation pressure (P<.001 and P<.05, respectively) and augmentation index at heart rate 75 bpm (P<.001 and P<.001, respectively) were significantly higher than in controls. Augmentation pressure and augmentation index at heart rate 75 bpm were significantly higher in early- compared with late-onset preeclampsia (P<.001) and in severe compared with mild preeclampsia (P<.001). Antihypertensive therapy with alpha methyldopa resulted in a significant fall in both augmentation pressure and augmentation index at heart rate 75 bpm in preeclampsia (P<.001) but not in gestational hypertension.
CONCLUSION: Arterial stiffness is increased in women with hypertensive disorders of pregnancy compared with normotensive controls. In preeclampsia, vascular stiffness was significantly improved by antihypertensive treatment with alpha methyldopa, but remained higher than in normotensive controls.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19300330     DOI: 10.1097/AOG.0b013e318197c392

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

Review 1.  Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction.

Authors:  Takuji Tomimatsu; Kazuya Mimura; Masayuki Endo; Keiichi Kumasawa; Tadashi Kimura
Journal:  Hypertens Res       Date:  2016-11-10       Impact factor: 3.872

2.  Vascular Function and Serum Lipids in Women with Spontaneous Preterm Delivery and Term Controls.

Authors:  Margo B Minissian; Sarah Kilpatrick; Chrisandra L Shufelt; Jo-Ann Eastwood; Wendie Robbins; Kathryn J Sharma; Linda Burnes Bolton; Mary-Lynn Brecht; Janet Wei; Galen Cook-Wiens; Lynn V Doering; C Noel Bairey Merz
Journal:  J Womens Health (Larchmt)       Date:  2019-08-07       Impact factor: 2.681

3.  Maternal arterial stiffness in women who subsequently develop pre-eclampsia.

Authors:  Makrina D Savvidou; Christina Kaihura; James M Anderson; Kypros H Nicolaides
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

4.  Measurement of area difference ratio of Photoplethysmographic pulse wave in patients with pre-eclampsia.

Authors:  Ying Feng; Dan Drzymalski; Baihui Zhao; Xuan Wang; Xinzhong Chen
Journal:  BMC Pregnancy Childbirth       Date:  2018-07-03       Impact factor: 3.007

Review 5.  Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors.

Authors:  Takuji Tomimatsu; Kazuya Mimura; Shinya Matsuzaki; Masayuki Endo; Keiichi Kumasawa; Tadashi Kimura
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

6.  Circulating Total Cell-Free DNA Levels Are Increased in Hypertensive Disorders of Pregnancy and Associated with Prohypertensive Factors and Adverse Clinical Outcomes.

Authors:  Lorena M Amaral; Valeria C Sandrim; Matthew E Kutcher; Frank T Spradley; Ricardo C Cavalli; Jose E Tanus-Santos; Ana C Palei
Journal:  Int J Mol Sci       Date:  2021-01-08       Impact factor: 6.208

Review 7.  No Hypertensive Disorder of Pregnancy; No Preeclampsia-eclampsia; No Gestational Hypertension; No Hellp Syndrome. Vascular Disorder of Pregnancy Speaks for All.

Authors:  Yifru Berhan
Journal:  Ethiop J Health Sci       Date:  2016-03

Review 8.  Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?

Authors:  F Mecacci; L Avagliano; F Lisi; S Clemenza; Caterina Serena; S Vannuccini; M P Rambaldi; S Simeone; S Ottanelli; F Petraglia
Journal:  Reprod Sci       Date:  2020-11-19       Impact factor: 3.060

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.